Accessibility help Skip to navigation Skip to content Skip to footer

Opioids and the Sackler family

The billionaire Sackler family and its company, Purdue Pharma, are named in lawsuits alleging their marketing tactics helped get a nation hooked on painkillers. The FT’s David Crow investigates

Purdue’s 2007 settlement with the US Department of Justice saw it plead guilty to criminal charges of misleading regulators and doctors over the addictive properties of OxyContin © Reuters

How Purdue’s ‘one-two’ punch fuelled the market for opioids
Accused of exaggerating the benefits of OxyContin, the company’s owners had a bigger share than realised
Purdue Pharma's 'one-two' punch
The FT’s David Crow explains how the Sackler family company got its hold on the opioid market
What next for the Sacklers? A pharma dynasty under siege
An investigation into the unfolding scandal of a company accused of fuelling America’s opioid crisis
Billionaire Sackler family owns second opioid drugmaker
Purdue owners set up Rhodes Pharma after criminal charges in 2007
Opioid billionaire granted patent for addiction treatment
Purdue owner Richard Sackler listed as inventor of drug to wean addicts off painkillers